Search Ontology:
ChEBI

orlistat

Term ID
CHEBI:94686
Synonyms
  • (-)-tetrahydrolipostatin
  • (2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl N-formyl-L-leucinate
  • (2S)-2-formamido-4-methylpentanoic acid [(2S)-1-[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]tridecan-2-yl] ester
  • Alli
  • N-formyl-L-leucine (1S)-1-{[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl}dodecyl ester
  • orlipastat
  • orlistat
  • orlistatum
  • Ro-18-0647
  • Xenical
Definition
A carboxylic ester resulting from the formal condensation of the carboxy group of N-formyl-L-leucine with the hydroxy group of (3S,4S)-3-hexyl-4-[(2S)-2-hydroxytridecyl]oxetan-2-one. A pancreatic lipase inhibitor, it is used as an anti-obesity drug.
References
  • cas:96829-58-2
  • drugcentral:1996
  • kegg.drug:D04028
  • lincs.smallmolecule:LSM-5724
  • patent:EP129748
  • patent:US4598089
  • pubmed:27793869
  • pubmed:28097013
  • pubmed:28191026
  • pubmed:28260907
  • pubmed:28387458
  • pubmed:28559211
  • pubmed:28588183
  • pubmed:28624425
  • reaxys:3658031
  • wikipedia.en:Orlistat
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from orlistat
Phenotype where environments contain orlistat
Phenotype modified by environments containing orlistat
Phenotype affecting orlistat
Human Disease Model